2,238 results on '"antibodies"'
Search Results
2. Patent Issued for Heterodimeric antibodies that bind CD3 and CD38 (USPTO 12129309)
3. Patent Issued for Antibodies against TIM3 and uses thereof (USPTO 12129297)
4. Patent Issued for Antibody variable domains targeting the NKG2D receptor (USPTO 12129300)
5. Patent Issued for Anti-interleukin-11 receptor subunit a (IL-11Ra) antibodies (USPTO 12129303)
6. OncoResponse Announces Phase 1 Results of the Clinical Trial of OR502, anti-LILRB2 Antibody, in Subjects with Advanced Cancer
7. Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy
8. Researchers Submit Patent Application, 'Anti-CCR8 Antibodies and Uses Thereof', for Approval (USPTO 20240352134)
9. Researchers Submit Patent Application, 'Anti-Cd48 Antibodies, Antibody Drug Conjugates, And Uses Thereof', for Approval (USPTO 20240352122)
10. Patent Issued for Anti-ROR1 antibody and use thereof (USPTO 12122830)
11. Patent Issued for Anti-PD-1 antibodies (USPTO 12122834)
12. Patent Issued for Anti-CD19 antibody drug conjugates (USPTO 12121589)
13. Patent Application Titled 'Antibodies Targeting Immunosuppressive B Cells' Published Online (USPTO 20240352156)
14. 'Anti-Cd73 Antibodies And Uses Thereof' in Patent Application Approval Process (USPTO 20240352143)
15. Studies from F. Hoffmann-La Roche Add New Findings in the Area of Cancer (Abstract A054: Recruiting innate immune cells universally: Development of a novel universal innate cell engager for cancer-immunotherapy)
16. Researchers Submit Patent Application, 'Anti-Tmprss2 Antibodies And Antigen-Binding Fragments', for Approval (USPTO 20240343831)
17. Patent Application Titled 'Antibody Against Glypican-3 And Application Thereof' Published Online (USPTO 20240342305)
18. Patent Application Titled 'Engineered T Cell Receptors Fused To Binding Domains From Antibodies' Published Online (USPTO 20240342215)
19. Patent Application Titled 'Anti-Pd-1 Antibody Pharmaceutical Composition And Use Thereof' Published Online (USPTO 20240342083)
20. Researchers Submit Patent Application, 'Treatment Of Cancers With An Antibody That Binds Lgr5 And Egfr', for Approval (USPTO 20240336689)
21. Researchers Submit Patent Application, 'Antibodies To Cd40', for Approval (USPTO 20240336695)
22. Researchers Submit Patent Application, 'Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer', for Approval (USPTO 20240335533)
23. Researchers Submit Patent Application, 'Anti-Cd47 Antibodies And Use Thereof', for Approval (USPTO 20240336681)
24. Patent Issued for Site-specific antibody-drug conjugation through glycoengineering (USPTO 12110338)
25. Patent Issued for Neutralizing antibodies to the avb8 integrin complex for immunotherapy (USPTO 12110334)
26. Patent Issued for Anti-CD27 antibodies and uses thereof (USPTO 12110337)
27. Patent Application Titled 'Pharmaceutical Compositions Of A B7-H3 Antibody And Use Of The Same' Published Online (USPTO 20240336687)
28. Study Results from Hadassah-Hebrew University Broaden Understanding of Lung Diseases and Conditions (Detection of Antibody-drug Conjugate-induced Interstitial Lung Disease Using Circulating Cell-free Dna)
29. Patent Application Titled 'Pharmaceutical Composition Containing Anti-Trop2 Antibody Drug Conjugate And Its Application' Published Online (USPTO 20240325564)
30. Patent Application Titled 'Antibodies Targeting Liv-1 And Uses Thereof' Published Online (USPTO 20240325555)
31. Researchers Submit Patent Application, 'Antibodies That Bind Psma And Gamma-Delta T Cell Receptors', for Approval (USPTO 20240317888)
32. Researchers Submit Patent Application, 'Antibodies And Antibody-Drug Conjugates Targeting Claudin 6', for Approval (USPTO 20240317851)
33. Patent Application Titled 'Use of Anti-EGFR/Anti-Met Antibody to Treat Gastric or Esophageal Cancer' Published Online (USPTO 20240317866)
34. Patent Issued for Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH) (USPTO 12091463)
35. Patent Application Titled 'Anti-Cldn18.2 Antibody Conjugates' Published Online (USPTO 20240307564)
36. Researchers Submit Patent Application, 'Antibody Molecules To Cd138 And Uses Thereof', for Approval (USPTO 20240301065)
37. Researchers Submit Patent Application, 'Antibodies To Pmel17 And Conjugates Thereof', for Approval (USPTO 20240299574)
38. Researchers Submit Patent Application, 'Anti-Tcr Antibody Molecules And Uses Thereof', for Approval (USPTO 20240301060)
39. Researchers Submit Patent Application, '2-Amino-4-Carboxamide-Benzazepine Immunoconjugates, And Uses Thereof', for Approval (USPTO 20240299569)
40. Patent Issued for Antibodies specific to delta 1 chain of T cell receptor (USPTO 12084500)
41. Patent Issued for Anti-ROR antibody constructs (USPTO 12084496)
42. 'Fibrosis Treatment With Anti-Trem2 Antibodies' in Patent Application Approval Process (USPTO 20240301059)
43. Researchers Submit Patent Application, 'Human Antibody Drug Conjugates Against Tissue Factor', for Approval (USPTO 20240294661)
44. Researchers Submit Patent Application, 'Cytotoxicity-Inducing Therapeutic Agent', for Approval (USPTO 20240294672)
45. Patent Issued for Single domain antibodies that bind to CD137 (USPTO 12077595)
46. Patent Issued for Antibodies specific to human NECTIN4 (USPTO 12077583)
47. Patent Issued for Bispecific antibodies for use in the treatment of hematological malignancies (USPTO 12077586)
48. Researchers Submit Patent Application, 'Radiolabeled Fibronectin Based Scaffolds And Antibodies And Theranostic Uses Thereof', for Approval (USPTO 20240277878)
49. Researchers Submit Patent Application, 'Antibodies Binding To Steap-1', for Approval (USPTO 20240279355)
50. Researchers Submit Patent Application, 'Antibody-Urease Conjugates For Therapeutic Purposes', for Approval (USPTO 20240277863)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.